6 completed. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
| Phase 2 | 1 | Completed 1 |
Follow Delayed Graft Function: new trials by email Literature Review of Delayed Graft Function trials Research Report on Delayed Graft Function
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Graft Acute Kidney Injury: Vitamin B3 to Facilitate Renal Recovery In the Early Life of a Transplant Nicotinamide treatment, Placebo treatment - Delayed Graft Function | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 204 | 2023-01-12 | 2024-07-10 |
| Better Evidence for Selecting Transplant Fluids Plasma-Lyte 148 (approx. pH 7.4) IV Infusion, 0.9% SODIUM CHLORIDE 9g/L injection BP - End Stage Kidney Disease, Delayed Graft Function | Phase 3 | Completed | The University of Queensland | 808 | 2018-01-26 | 2024-10-15 |
| QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant QPI-1002, Placebo - Delayed Graft Function | Phase 3 | Completed | Quark Pharmaceuticals | 594 | 2016-03-01 | 2020-05-13 |
| Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study) Eculizumab, Placebo - Delayed Graft Function | Phase 2 / Phase 3 | Completed | Alexion Pharmaceuticals, Inc. | 288 | 2014-08-21 | 2018-12-17 |
| Remote Ischemic Preconditioning In Abdominal Organ Transplantation RIPC by Inflation of Pneumatic Tourniquet - Kidney Disease, Liver Disease | Phase 3 | Completed | University of Medicine and Dentistry of New Jersey | 85 | 2009-04-01 | 2015-01-14 |
| N-acetyl-cysteine (NAC) and Kidney Graft Function N-acetylcysteine - Brain Death, Chronic Renal Insufficiency | Phase 3 | Completed | Institut d'Anesthesiologie des Alpes Maritimes | 236 | 2006-09-01 | 2011-07-12 |
Acute Kidney Injury (1) · Brain Death (1) · Kidney Cortex Necrosis (1) · Kidney Diseases (1) · Kidney Failure, Chronic (1) · Liver Diseases (1) · Pancreatic Diseases (1) · Renal Insufficiency, Chronic (1) · Reperfusion Injury (1)
Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Male Urogenital Diseases (4) · Urogenital Diseases (4) · Urologic Diseases (4) · Kidney Diseases (3) · Renal Insufficiency (3) · Chronic Disease (2) · Disease Attributes (2) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Coma (1)
Acetylcysteine (1) · Infusions, Intravenous (1) · Niacinamide (1) · Plasma-lyte 148 (1) · Plasmalyte A (1) · Saline Solution (1) · Sodium Chloride (1) · eculizumab (1)
Alexion Pharmaceuticals, Inc. (1) · Assistance Publique - Hôpitaux de Paris (1) · Institut d'Anesthesiologie des Alpes Maritimes (1) · Quark Pharmaceuticals (1) · The University of Queensland (1) · University of Medicine and Dentistry of New Jersey (1)
France (4) · Australia (3) · United States (3) · Brazil (2) · Canada (2) · Czechia (2) · Germany (2) · Spain (2) · Argentina (1) · Belgium (1) · Italy (1) · Netherlands (1) · New Zealand (1)
Baburao Koneru, M.D. (1) · Carole R Ichai, MD, PhD (1) · John Holman, M.D.,Ph.D. (1) · Michael Collins, MBChB,FRACP,PhD (1) · Steven Chadban, BMed(hons),FRACP,PhD (1)
PMID 25250647, PMID 32450917, PMID 35042554, PMID 37343576, PMID 37916745, PMID 42763038